His primary areas of study are Angiogenesis, Cell biology, Internal medicine, Cardiology and Fibroblast growth factor. His work carried out in the field of Angiogenesis brings together such families of science as Endothelial stem cell, Vascular endothelial growth factor and Pathology. The study incorporates disciplines such as Cell, Endothelium, In vitro and Immunology in addition to Cell biology.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Surgery. He usually deals with Cardiology and limits it to topics linked to Basic fibroblast growth factor and Heparin. His Fibroblast growth factor research includes elements of Syndecan 1 and Growth factor.
Michael Simons spends much of his time researching Cell biology, Angiogenesis, Internal medicine, Cardiology and Signal transduction. His study focuses on the intersection of Cell biology and fields such as Fibroblast growth factor with connections in the field of Growth factor. His study in Angiogenesis is interdisciplinary in nature, drawing from both Vascular endothelial growth factor and Pathology.
His research is interdisciplinary, bridging the disciplines of Endocrinology and Internal medicine. His Signal transduction research incorporates elements of Cancer research, Receptor, Molecular biology, Phosphorylation and Neuropilin 1. His Ischemia research is multidisciplinary, incorporating elements of Hemodynamics and Surgery.
His primary scientific interests are in Cell biology, Signal transduction, Angiogenesis, Endothelium and Immunology. His studies in Cell biology integrate themes in fields like Endothelial stem cell, Vascular endothelial growth factor A, Vascular endothelial growth factor, Fibroblast growth factor and Arteriogenesis. His Signal transduction study combines topics in areas such as Endocrinology, Cancer research, Internal medicine, Phosphorylation and Neuropilin 1.
Michael Simons works on Internal medicine which deals in particular with Myocardial infarction. Michael Simons studied Angiogenesis and Protein kinase B that intersect with PI3K/AKT/mTOR pathway. The Endothelium study combines topics in areas such as Mesenchymal stem cell and Vascular permeability.
The scientist’s investigation covers issues in Cell biology, Signal transduction, Angiogenesis, Fibroblast growth factor and Immunology. His Cell biology research includes themes of Vascular endothelial growth factor A, Vascular endothelial growth factor, Kinase insert domain receptor, Arteriogenesis and Endothelium. His Signal transduction research incorporates themes from Syndecan 1, Endocrinology, Cancer research, Phosphorylation and Neuropilin 1.
His Angiogenesis research is within the category of Internal medicine. His research integrates issues of Neointima, Regeneration and Receptor tyrosine kinase in his study of Fibroblast growth factor. The concepts of his Immunology study are interwoven with issues in Endothelial stem cell and Progenitor cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mosaic organization of DNA nucleotides
C.-K. Peng;C.-K. Peng;C.-K. Peng;S. V. Buldyrev;S. V. Buldyrev;S. V. Buldyrev;S. Havlin;S. Havlin;S. Havlin;M. Simons;M. Simons;M. Simons.
Physical Review E (1994)
Long-range correlations in nucleotide sequences
C.-K. Peng;S. V. Buldyrev;A. L. Goldberger;S. Havlin;S. Havlin.
Antisense c- myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo
Michael Simons;Michael Simons;Elazer R. Edelman;Jean-Luc DeKeyser;Robert Langer.
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2 Double-Blind, Randomized, Controlled Clinical Trial
Michael Simons;Brian H. Annex;Roger J. Laham;Neal Kleiman.
Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
Massimiliano Mazzone;Massimiliano Mazzone;Daniela Dettori;Daniela Dettori;Daniela Dettori;Rodrigo Leite de Oliveira;Rodrigo Leite de Oliveira;Sonja Loges;Sonja Loges.
Long-range correlation properties of coding and noncoding DNA sequences: GenBank analysis
S. V. Buldyrev;A. L. Goldberger;S. Havlin;R. N. Mantegna.
Physical Review E (1995)
Mechanisms and regulation of endothelial VEGF receptor signalling
Michael Simons;Emma Gordon;Lena Claesson-Welsh.
Nature Reviews Molecular Cell Biology (2016)
Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus An Expert Panel Summary
M. Simons;R. O. Bonow;N. A. Chronos;D. J. Cohen.
Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery: Results of a Phase I Randomized, Double-Blind, Placebo-Controlled Trial
Roger J. Laham;Frank W. Sellke;Elazer R. Edelman;Justin D. Pearlman.
Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice.
Anne Braun;Bernardo L. Trigatti;Mark J. Post;Kaori Sato.
Circulation Research (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: